• Abstract
• Full-Text PDF [300 KB]
• Full-Text XML
• Article Versions Notes

• Article Statistics
• PubMed/Medline
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Ridolfi, E
• Fenoglio, C
• Cantoni, C
• Calvi, A
• De Riz, M
• Pietroboni, A
• Villa, C
• Serpente, M
• Bonsi, R
• Vercellino, M
• Cavalla, P
• Galimberti, D
• Scarpini, E
• [+] on Google Scholar
• Ridolfi, E
• Fenoglio, C
• Cantoni, C
• Calvi, A
• De Riz, M
• Pietroboni, A
• Villa, C
• Serpente, M
• Bonsi, R
• Vercellino, M
• Cavalla, P
• Galimberti, D
• Scarpini, E
• [+] on PubMed
• Ridolfi, E
• Fenoglio, C
• Cantoni, C
• Calvi, A
• De Riz, M
• Pietroboni, A
• Villa, C
• Serpente, M
• Bonsi, R
• Vercellino, M
• Cavalla, P
• Galimberti, D
• Scarpini, E

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter

This article is

• freely available
• re-usable

Int. J. Mol. Sci. 2013, 14(3), 4375-4384; doi:10.3390/ijms14034375

Article

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis

Elisa Ridolfi ¹ , Chiara Fenoglio ^1,* , Claudia Cantoni ¹ , Alberto Calvi ¹ , Milena De Riz ¹ , Anna Pietroboni ¹ , Chiara Villa ¹ , Maria Serpente ¹ , Rossana Bonsi ¹ , Marco Vercellino ² , Paola Cavalla ² , Daniela Galimberti ¹  and Elio Scarpini ¹

¹ Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, University of Milan, IRCCS Ospedale Maggiore Policlinico, Via F.Sforza 35, 20122 Milan, Italy ² Department of Neuroscience, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Corso Bramante 88, 10126 Turin, Italy

* Author to whom correspondence should be addressed.

Received: 5 December 2012; in revised form: 19 February 2013 / Accepted: 20 February 2013 / Published: 25 February 2013

(This article belongs to the Section Molecular Pathology)

Download PDF Full-Text [300 KB, Updated Version, uploaded 26 February 2013 14:25 CET]

The original version is still available [389 KB, uploaded 25 February 2013 13:51 CET]

Abstract: Evidence underlines the importance of microRNAs (miRNAs) in the pathogenesis of multiple sclerosis (MS). Based on the fact that miRNAs are present in human biological fluids, we previously showed that miR-223, miR-23a and miR-15b levels were downregulated in the sera of MS patients versus controls. Here, the expression levels of these candidate miRNAs were determined in peripheral blood mononuclear cells (PBMCs) and the serum of MS patients, in addition to three genotyped single nucleotide polymorphisms (SNPs). Mapping in the genomic regions of miR-223, miR-23a and miR-15b genes, 399 cases and 420 controls were tested. Expression levels of miR-223 and miR-23a were altered in PBMCs from MS patients versus controls. Conversely, there were no differences in the expression levels of miR-15b. A significantly decreased genotypic frequency of miR-223 rs1044165 T/T genotype was observed in MS patients. Moreover, the allelic frequency of miR-23a rs3745453 C allele was significantly increased in patients versus controls. In contrast, there were no differences in the distribution of miR-15b SNP. In conclusion, our results suggest that miR-223 and miR-23a could play a role in the pathogenesis of MS. Moreover, miR-223 rs1044165 polymorphism likely acts as a protective factor, while miR-23a rs3745453 variant seems to act as a risk factor for MS.

Keywords: multiple sclerosis; microRNA; gene expression; association analysis

Article Statistics

Cite This Article